Expectations that two Covid-19 vaccines could get emergency FDA approval, which would make up to 40 million doses available before the end of the year, had investors in a risk-on mood.
Sign up to access the rest of this content!
This content is not available to free users. Sign up for a paid account to access the rest of this content.